Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion

• Published in: Discover. Oncology 2024-05, Vol.15 (1), p.149-149, Article 149
• Main Authors: Liang, Hongxin, Zheng, Yong, Huang, Zekai, Dai, Jinchi, Yao, Lintong, Xie, Daipeng, Chen, Duo, Qiu, Hongrui, Wang, Huili, Li, Hao, Leng, Jinhang, Tang, Ziming, Zhang, Dongkun, Zhou, Haiyu
• Format: Article
• Language: English
• Subjects: Adaptive immunity; Analysis; Biomarkers; Cancer Research; Cancer therapies; CD47; CD8 + T cells; Correlation analysis; Cytotoxicity; Gene expression; Immunology; Immunotherapy; Internal Medicine; Lymphocytes; Medical prognosis; Medicine; Medicine & Public Health; Molecular Medicine; Monoclonal antibodies; Oncology; Pan-cancer; Proteins; Radiotherapy; Surgical Oncology; T cell receptors; T-cell exhausted; Tumor necrosis factor-TNF; Tumors
• ISSN: 2730-6011; 2730-6011
• DOI: 10.1007/s12672-024-00951-z

Purpose The research endeavors to explore the implications of CD47 in cancer immunotherapy effectiveness. Specifically, there is a gap in comprehending the influence of CD47 on the tumor immune microenvironment, particularly in relation to CD8 + T cells. Our study aims to elucidate the prognostic and immunological relevance of CD47 to enhance insights into its prospective utilities in immunotherapeutic interventions. Methods Differential gene expression analysis, prognosis assessment, immunological infiltration evaluation, pathway enrichment analysis, and correlation investigation were performed utilizing a combination of R packages, computational algorithms, diverse datasets, and patient cohorts. Validation of the concept was achieved through the utilization of single-cell sequencing technology. Results CD47 demonstrated ubiquitous expression across various cancer types and was notably associated with unfavorable prognostic outcomes in pan-cancer assessments. Immunological investigations unveiled a robust correlation between CD47 expression and T-cell infiltration rather than T-cell exclusion across multiple cancer types. Specifically, the CD47-high group exhibited a poorer prognosis for the cytotoxic CD8 + T cell Top group compared to the CD47-low group, suggesting a potential impairment of CD8 + T cell functionality by CD47. The exploration of mechanism identified enrichment of CD47-associated differentially expressed genes in the CD8 + T cell exhausted pathway in multiple cancer contexts. Further analyses focusing on the CD8 TCR Downstream Pathway and gene correlation patterns underscored the significant involvement of TNFRSF9 in mediating these effects. Conclusion A robust association exists between CD47 and the exhaustion of CD8 + T cells, potentially enabling immune evasion by cancer cells and thereby contributing to adverse prognostic outcomes. Consequently, genes such as CD47 and those linked to T-cell exhaustion, notably TNFRSF9, present as promising dual antigenic targets, providing critical insights into the field of immunotherapy.